Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JT002 in Adult Patients With Seasonal Allergic Rhinitis

NCT06861101 is registered in ClinicalTrials.gov with Shanghai JunTop Biosciences Co., LTD as lead sponsor.

NCT NCT06861101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06861101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JT002 in Adult Patients With Seasonal Allergic Rhinitis
Lead sponsor
Shanghai JunTop Biosciences Co., LTD
Phase
Phase 2
Overall status
Completed
Start date
February 24, 2025
Completion date
May 14, 2025
Enrollment
370 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis